IMRIS Announces $40 Million Initial Public Offering


    WINNIPEG, Oct. 26 /CNW Telbec/ - IMRIS Inc. ("IMRIS") announced today
that it has filed its final prospectus and entered into an underwriting
agreement with a syndicate of underwriters led by RBC Capital Markets and
including BMO Capital Markets, TD Securities Inc., Canaccord Capital
Corporation and GMP Securities L.P., in relation to its $40,000,000 initial
public offering of common shares at a price of $6.00 per common share. IMRIS
has also granted to the underwriters an option, exercisable until 30 days
following closing of the offering, to acquire an additional 1,000,000 common
shares on the same terms and conditions to cover over-allotments, if any, and
for market stabilization purposes. It is anticipated that closing of the
offering will occur on November 2, 2007 and that the common shares will begin
trading that day on the TSX under the symbol "IM".
    The securities offered have not been, and will not be, registered under
the United States Securities Act of 1933, as amended, and may not be offered
or sold in the United States absent registration or any applicable exemption
from the registration requirement of such Act. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of these securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful.

    About IMRIS

    IMRIS is a global leader in the supply of fully-integrated,
intra-operative imaging solutions designed to assist in the treatment of
disease and to measurably improve patient outcomes. Our flagship product,
IMRISneuro, is a neurosurgical MR imaging system which provides near
real-time, high-resolution MR imaging with integrated data management and
display systems. The combination of high resolution MR images, improved
patient safety, enhanced surgical efficiency, a fully integrated operating
room, and the potential for increased financial viability contributes to a
surgical imaging offering that we believe has not previously been available to
medical teams and their patients. For more information about IMRIS please
visit the company's website at

    Forward-Looking Statements

    This press release may contain or refer to forward-looking information
based on current expectations. These statements should not be read as
guarantees of future performance or results. Such statements involve known and
unknown risks, uncertainties and other factors that may cause actual results,
performance or achievements to be materially different from those implied by
such statements. Although such statements are based on management's reasonable
assumptions, there can be no assurance that actual results will be consistent
with such statements. These forward-looking statements are made as of the date
hereof and we assume no responsibility to update or revise them to reflect new
events or circumstances.

For further information:

For further information: Susan McLeod, Manager, Marketing
Communications, (204) 480-7070,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890